Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • Hypoxia-inducible factors in disease pathophysiology and therapeutics (Oct 2020)
    • Latency in Infectious Disease (Jul 2020)
    • Immunotherapy in Hematological Cancers (Apr 2020)
    • Big Data's Future in Medicine (Feb 2020)
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • View all review series ...
  • Viewpoint
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a letter
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need Help? E-mail the JCI
  • Top
  • Abstract
  • Supplemental material
  • Version history
  • Article usage
  • Citations to this article

Advertisement

ResearchIn-Press PreviewInfectious diseaseInflammation Free access | 10.1172/JCI140853

Tetracyclines improve experimental lymphatic filariasis pathology by disrupting interleukin-4 receptor-mediated lymphangiogenesis

Julio Furlong-Silva,1 Stephen D. Cross,1 Amy E. Marriott,1 Nicolas Pionnier,1 John Archer,1 Andrew Steven,1 Stefan Schulte-Merker,3 Matthias Mack,4 Young-Kwon Hong,5 Mark J. Taylor,1 and Joseph D. Turner1

1Centre for Drugs & Diagnostics, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom

2Centre for Drugs & Diagnostics, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Livrerpool, United Kingdom

3Faculty of Medicine, Institute for Cardiovascular Organogenesis and Regeneration, Utrecht, United Kingdom

4Department of Internal Medicine II, University of Regensburg, Regensburg, Germany

5Department of Surgery, University of Southern California, Los Angeles, United States of America

Find articles by Furlong-Silva, J. in: JCI | PubMed | Google Scholar |

1Centre for Drugs & Diagnostics, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom

2Centre for Drugs & Diagnostics, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Livrerpool, United Kingdom

3Faculty of Medicine, Institute for Cardiovascular Organogenesis and Regeneration, Utrecht, United Kingdom

4Department of Internal Medicine II, University of Regensburg, Regensburg, Germany

5Department of Surgery, University of Southern California, Los Angeles, United States of America

Find articles by Cross, S. in: JCI | PubMed | Google Scholar

1Centre for Drugs & Diagnostics, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom

2Centre for Drugs & Diagnostics, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Livrerpool, United Kingdom

3Faculty of Medicine, Institute for Cardiovascular Organogenesis and Regeneration, Utrecht, United Kingdom

4Department of Internal Medicine II, University of Regensburg, Regensburg, Germany

5Department of Surgery, University of Southern California, Los Angeles, United States of America

Find articles by Marriott, A. in: JCI | PubMed | Google Scholar |

1Centre for Drugs & Diagnostics, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom

2Centre for Drugs & Diagnostics, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Livrerpool, United Kingdom

3Faculty of Medicine, Institute for Cardiovascular Organogenesis and Regeneration, Utrecht, United Kingdom

4Department of Internal Medicine II, University of Regensburg, Regensburg, Germany

5Department of Surgery, University of Southern California, Los Angeles, United States of America

Find articles by Pionnier, N. in: JCI | PubMed | Google Scholar |

1Centre for Drugs & Diagnostics, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom

2Centre for Drugs & Diagnostics, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Livrerpool, United Kingdom

3Faculty of Medicine, Institute for Cardiovascular Organogenesis and Regeneration, Utrecht, United Kingdom

4Department of Internal Medicine II, University of Regensburg, Regensburg, Germany

5Department of Surgery, University of Southern California, Los Angeles, United States of America

Find articles by Archer, J. in: JCI | PubMed | Google Scholar

1Centre for Drugs & Diagnostics, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom

2Centre for Drugs & Diagnostics, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Livrerpool, United Kingdom

3Faculty of Medicine, Institute for Cardiovascular Organogenesis and Regeneration, Utrecht, United Kingdom

4Department of Internal Medicine II, University of Regensburg, Regensburg, Germany

5Department of Surgery, University of Southern California, Los Angeles, United States of America

Find articles by Steven, A. in: JCI | PubMed | Google Scholar |

1Centre for Drugs & Diagnostics, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom

2Centre for Drugs & Diagnostics, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Livrerpool, United Kingdom

3Faculty of Medicine, Institute for Cardiovascular Organogenesis and Regeneration, Utrecht, United Kingdom

4Department of Internal Medicine II, University of Regensburg, Regensburg, Germany

5Department of Surgery, University of Southern California, Los Angeles, United States of America

Find articles by Schulte-Merker, S. in: JCI | PubMed | Google Scholar |

1Centre for Drugs & Diagnostics, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom

2Centre for Drugs & Diagnostics, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Livrerpool, United Kingdom

3Faculty of Medicine, Institute for Cardiovascular Organogenesis and Regeneration, Utrecht, United Kingdom

4Department of Internal Medicine II, University of Regensburg, Regensburg, Germany

5Department of Surgery, University of Southern California, Los Angeles, United States of America

Find articles by Mack, M. in: JCI | PubMed | Google Scholar

1Centre for Drugs & Diagnostics, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom

2Centre for Drugs & Diagnostics, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Livrerpool, United Kingdom

3Faculty of Medicine, Institute for Cardiovascular Organogenesis and Regeneration, Utrecht, United Kingdom

4Department of Internal Medicine II, University of Regensburg, Regensburg, Germany

5Department of Surgery, University of Southern California, Los Angeles, United States of America

Find articles by Hong, Y. in: JCI | PubMed | Google Scholar |

1Centre for Drugs & Diagnostics, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom

2Centre for Drugs & Diagnostics, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Livrerpool, United Kingdom

3Faculty of Medicine, Institute for Cardiovascular Organogenesis and Regeneration, Utrecht, United Kingdom

4Department of Internal Medicine II, University of Regensburg, Regensburg, Germany

5Department of Surgery, University of Southern California, Los Angeles, United States of America

Find articles by Taylor, M. in: JCI | PubMed | Google Scholar |

1Centre for Drugs & Diagnostics, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom

2Centre for Drugs & Diagnostics, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Livrerpool, United Kingdom

3Faculty of Medicine, Institute for Cardiovascular Organogenesis and Regeneration, Utrecht, United Kingdom

4Department of Internal Medicine II, University of Regensburg, Regensburg, Germany

5Department of Surgery, University of Southern California, Los Angeles, United States of America

Find articles by Turner, J. in: JCI | PubMed | Google Scholar |

Published January 12, 2021 - More info

J Clin Invest. https://doi.org/10.1172/JCI140853.
Copyright © 2021, American Society for Clinical Investigation
Published January 12, 2021 - Version history
View PDF
Abstract

Lymphatic filariasis is the major global cause of non-hereditary lymphoedema. We demonstrate the filarial nematode, Brugia malayi, induces lymphatic remodelling and impaired lymphatic drainage following parasitism of limb lymphatics in a mouse model. Lymphatic insufficiency was associated with elevated circulating lymphangiogenic mediators, including vascular endothelial growth factor C. Lymphatic insufficiency was dependent on type-2 adaptive immunity, interleukin-4 receptor, recruitment of C-C chemokine receptor-2 monocytes and alternatively-activated macrophages with pro-lymphangiogenic phenotype. Oral treatments with second-generation tetracyclines improved lymphatic function, while other classes of antibiotic had no significant effect. Second-generation tetracyclines directly targeted lymphatic endothelial cell proliferation and modified type-2 pro-lymphangiogenic macrophage development. Doxycycline treatment impeded monocyte recruitment, inhibited polarisation of alternatively-activated macrophages and suppressed T cell adaptive immune responses following infection. Our results determine a mechanism-of-action for the anti-morbidity effects of doxycycline in filariasis and supports clinical evaluation of second-generation tetracyclines as affordable, safe therapeutics for lymphoedemas of chronic inflammatory origin.

Graphical Abstract
graphical abstract
Supplemental material

View Supplemental File 1

View

View Supplemental File 2

View Supplemental Movie 1

Version history
  • Version 1 (January 12, 2021): In-Press Preview

Article tools

  • View PDF
  • Download citation information
  • Send a letter
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need Help? E-mail the JCI

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Supplemental material
  • Version history
Advertisement
Advertisement
Follow JCI:
Copyright © 2021 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts